SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4251isis 10Q: xml.10kwizard.combob zagorin-11/9/2007
4250Bob I tried posting the chart and news for GENZ from SI but it doesn't workMJ-11/9/2007
4249Genzyme Eyes Isis Drug Matthew Herper, 11.09.07, 6:00 AM ET (Forbes) Isis Pharmbob zagorin-11/9/2007
4248full transcript of conf. call seekingalpha.combob zagorin-11/9/2007
4247analyst meeting in nyc next tuesday. also webcast. more detailed reports....bob zagorin-11/8/2007
4246Isis Reports Financial Results and Highlights for Third Quarter of 2007 Thursdaybob zagorin-11/8/2007
4245Sol Sherry Distinguished Lecture in Thrombosis: Antithrombotic Treatment-Experimbob zagorin-11/6/2007
4244November 6, 2007 Hope After Failure of New Cholesterol Drug By ALEX BERENSON ORbob zagorin-11/6/2007
4243Webcast Alert: Isis Pharmaceuticals Announces Third Quarter 2007 Financial Resulbob zagorin-11/1/2007
4242The Heart Drug Junkyard Matthew Herper, 10.31.07, 10:02 AM ET (Forbes) Investorbob zagorin-10/31/2007
4241Isis to Receive Up to $9.9 Million in Funding to Discover and Develop an Antisenbob zagorin-10/26/2007
4240Regulus Therapeutics and Collaborators Announce Publication of New Research on tbob zagorin-10/25/2007
4239Archemix and Isis Pharmaceuticals Form Strategic Alliance for Aptamer Drug Discobob zagorin-10/23/2007
4238isis licensee files ipo archemix ipo.. Archemix Corp., a Cambridge, Mass.-basebob zagorin-10/23/2007
4237Isis has in the last few years made a point of going after targets that are not tuck-10/23/2007
4236Update from Boenning and Scattergood: 22-Oct-07 08:03 ET ISIS Pharm: SGLT2 inhbob zagorin-10/22/2007
4235Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for bob zagorin-10/18/2007
4234optionMonster's take: Isis Pharmaceutical (ISIS) hitting new 52-week high Jbob zagorin-10/18/2007
4233isis again mentioned as big pharma takeover target on cnbc's fast money tonibob zagorin-10/17/2007
4232new coverage on ISIS Boenning & Scattergood ISIS Pharmaceuticals (ISIS/NAbob zagorin-10/17/2007
4231Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newlybob zagorin-10/16/2007
4230Carlsbad biotech goes on a tear By: BRADLEY J. FIKES - Staff Writer CARLSBAD -bob zagorin-10/14/2007
4229ibis presentation caphld.orgbob zagorin-10/14/2007
4228ore details on new wachovia coverage on isis (from iv board) <Re: wachovia bob zagorin-10/11/2007
4227This selloff then becomes a buying opportunity. Unbelievable but options expireMJ-10/10/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News